Prostate cancer: Estimating the benefits of PSA screening

Nature Reviews Urology

Volumn 6, Issue 6, 2009, Pages 301-303

  Vickers, Andrew J ^a   Lilja, Hans ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ANTIGEN DETECTION; CANCER MORTALITY; CANCER SCREENING; PRIORITY JOURNAL; PROSTATE CANCER; SHORT SURVEY; ADULT; AGED; BLOOD; HUMAN; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; NOTE; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL; STANDARD; STATISTICS;

ADULT; AGED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TUMOR MARKERS, BIOLOGICAL;

EID: 70349278598     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2009.95     Document Type: Short Survey

References (10)

1. Andriole, G. L. et al. Mortality results from a randomized prostate-cancer screening trial. N. Engl. J. Med. 360, 1310-1319 (2009).
2. schröder, F. H. et al. screening and prostatecancer mortality in a randomized european study. N. Engl. J. Med. 360, 1320-1328 (2009).
3. Lilja, H. et al. Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years. J. Clin. Oncol. 25, 431-436 (2007).
4. Ulmert, D. et al. Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study. BMC Med. 6, 6 (2008).
5. Postma, R. et al. Cancer detection and cancer characteristics in the european Randomized study of screening for Prostate Cancer (eRsPC)-section Rotterdam: a comparison of two rounds of screening. Eur. Urol. 52, 89-97 (2007).
6. Aus, G., Bergdahl, s., Lodding, P., Lilja, H. & Hugosson, J. Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer-results from a prospective, population-based randomized controlled trial. Eur. Urol. 51, 659-664 (2007).
7. Thompson, i. M. The influence of finasteride on the development of prostate cancer. N. Engl. J. Med. 349, 215-224 (2003).
8. Zietman, A. L. Comparison of conventionaldose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294, 1233-1239 (2005).
9. vickers, A. J. et al. The surgical learning curve for prostate cancer control after radical prostatectomy. J. Natl Cancer Inst. 99, 1171-1177 (2007).
10. vickers, A. J. et al. effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. Eur. Urol. 53, 960-966 (2008).